Clinical Trial Update: Phase I Study of Induction Therapy With VELCADE and Vorinostat in Patients With Surgically Resectable Non-Small Cell Lung Cancer [Phase 1]

View source ↗

Summary

A Phase I trial update reports completion of induction therapy with Velcade (bortezomib) and vorinostat in patients with surgically resectable non-small cell lu…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Non-small Cell Lung Cancer

Drugs mentioned

• Velcade (bortezomib)
• Vorinostat (vorinostat)

Snippet

Sponsor: University of Virginia | Conditions: Non Small Cell Lung Cancer | Phase 1 | Status: COMPLETED